Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

F Ambrosch

Vaccine

VaccinationMucosal VaccinationVaccine DevelopmentMedicineImmunology +7

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

G Wiedermann, F Ambrosch, Herwig Kollaritsch, +7

Vaccine

VaccinationVaccine SafetyHealthy Adult VolunteersViral HepatitisImmunology +5

Influenza vaccination in 22 developed countries: an update to 1995

David S. Fedson, Yoshio Hirota, Hak-Kyoon Shin, +19

Vaccine

VaccinationGlobal HealthInternational HealthInfluenza VaccinationVaccine Efficacy +7

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

F Ambrosch, G Wiedermann, Francis André, +7

Journal of Medical Virology

Influenza Vaccination in 29 Countries

F Ambrosch, David S. Fedson

PharmacoEconomics

VaccinationGlobal HealthInternational HealthInfluenza VaccinationInfluenza Vaccine +6

Inactivated hepatitis A vaccine: long-term antibody persistence

G Wiedermann, Michael Kundi, F Ambrosch, +3

Vaccine

VaccinationVaccine DevelopmentVaccine ResearchViral HepatitisImmunology +4

A hepatitis B vaccine formulated with a novel adjuvant system

F Ambrosch, G Wiedermann, Michael Kundi, +6

Vaccine

VaccinationViral HepatitisNovel Adjuvant SystemVaccine TargetImmunology +7

Simultaneous vaccination against hepatitis A and B: results of a controlled study

F Ambrosch, Francis André, A. Delem, +5

Vaccine

Hepatitis DVaccinationSimultaneous VaccinationViral HepatitisHepatitis A +5

Persistence of vaccine-induced antibody to hepatitis A virus

G Wiedermann, F Ambrosch, Francis André, +3

Vaccine

VaccinationVaccine DevelopmentImmunologyHepatitisVirology +3

Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.

F Ambrosch, W Frisch-Niggemeyer, Peter G. Kremsner, +4

PubMed

ImmunologyHepatitis BYeast CellsImmunotherapyYeast-derived Vaccine +15